NCT04053439
- Conditions
- Chemotherapeutic Toxicity, Hemic and Lymphatic Diseases, Immune System Diseases, +6 more
- Locations
-
- Sunnybrook Health Sciences Centre Toronto, Ontario, Canada
Clinical trial condition
Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.
NCT04053439
NCT06516679
NCT04827810
NCT05549102
NCT07008885
NCT07009002
NCT06871176
NCT05618041
NCT07032129
NCT07032103